Sorafenib with ASC-J9<sup>®</sup>synergistically suppresses the HCC progression<i>via</i>altering the pSTAT3-CCL2/Bcl2 signalsJunjie Xu, Chawnshang Chang, Gonghui Li et al.|International Journal of Cancer|2016Cited by 37